Release Details
EXL Reports 2020 First Quarter Results
2020 First Quarter Revenues of
Q1 Diluted EPS (GAAP) of
Q1 Adjusted Diluted EPS (Non-GAAP) of
“EXL’s employees have demonstrated ingenuity and creativity and risen to the challenges presented by the COVID-19 pandemic. We acted swiftly, to ensure the health and safety of our employees and partnered with our clients to achieve business resiliency with minimal disruption. As of today, we are able to meet over 95% of our clients’ delivery needs with the ‘work from home’ model on a global basis.
“The scale and speed of the disruption caused by COVID-19 has forced every business in the world to take a hard look at their operating business model, reinvent core functions and quickly adjust their cost structures to more closely align with the updated revenue expectations.”
As part of this effort, today we announced that the Company’s executive management team had recommended to the Compensation Committee, and the Committee accepted, temporary salary reductions for the Company’s senior leadership. Synchronous with this decision the Company’s non-executive directors have accepted a temporary reduction to their annual cash retainers. These reductions were effective
Financial Highlights: First Quarter 2020
Effective
- Revenues for the quarter ended
March 31, 2020 increased to$246.0 million compared to$239.6 million for the first quarter of 2019, an increase of 2.7% on a reported basis and 3.4% on a constant currency basis from the first quarter of 2019. Revenues declined by 4.2% sequentially on a reported basis and 3.8% on a constant currency basis, from the fourth quarter of 2019.
| Revenues | Gross Margin | |||||||||||||
| Three months ended | Three months ended | |||||||||||||
| Reportable Segments | ||||||||||||||
| (dollars in millions) | ||||||||||||||
| Insurance | $ | 83.7 | $ | 81.3 | 29.6 | % | 32.0 | % | ||||||
| Healthcare | 27.0 | 22.2 | 27.5 | % | 20.0 | % | ||||||||
| Emerging Business | 42.8 | 49.1 | 40.5 | % | 44.4 | % | ||||||||
| Analytics | 92.5 | 87.0 | 36.6 | % | 34.6 | % | ||||||||
| Total Revenues, net | $ | 246.0 | $ | 239.6 | 33.9 | % | 34.4 | % | ||||||
- Operating income margin for the quarter ended
March 31, 2020 was 11.2%, compared to an operating income margin of 7.0% for the first quarter of 2019 and operating income margin of 9.1% for the fourth quarter of 2019. During the quarter endedMarch 31, 2019 andDecember 31, 2019 , we recorded impairment and restructuring charges of$1.2 million and$1.4 million , respectively, related to the wind down of the Health Integrated business, which reduced our operating income margin by 50 basis points for both the periods. Adjusted operating income margin for the quarter endedMarch 31, 2020 was 14.8% compared to 12.8% for the first quarter of 2019 and 13.3% for the fourth quarter of 2019.
- Diluted earnings per share for the quarter ended
March 31, 2020 was$0.65 compared to$0.42 for the first quarter of 2019 and$0.62 for the fourth quarter of 2019. During the quarter endedMarch 31, 2019 andDecember 31, 2019 we recorded impairment and restructuring charges of$1.2 million ($0.9 million net of tax) and$1.4 million ($1.0 million net of tax), respectively, related to the wind down of the Health Integrated business, which reduced our diluted earnings per share by$0.03 for both the periods. Adjusted diluted earnings per share for the quarter endedMarch 31, 2020 was$0.81 compared to$0 .71for the first quarter of 2019 and$0.79 for the fourth quarter of 2019.
Business Highlights: First Quarter 2020
- Won 10 new clients in the first quarter of 2020, with 5 each in our operations management businesses and Analytics.
- Recognized as a Leader in Everest’s 2020 PEAK ranking for Property & Casualty (P&C) Insurance BPO Services.
- Appointed
Anita Mahon to the role of Executive Vice President, Chief Growth and Strategy Officer and member of the Executive Committee.
Post-First Quarter Highlights
- In April, we repaid
$100 million of amounts previously drawn from our Credit Facility in March to address cash needs due to the COVID-19 pandemic. We continue to have$200 million available from our Credit Facility.
Conference Call
To listen to the conference call via phone, please dial 1-877-303-6384, or if dialing internationally, 1-224-357-2191 and an operator will assist you. For those who cannot access the live broadcast, a replay will be available on the EXL website ir.exlservice.com for a period of twelve months.
About
EXL (NASDAQ: EXLS) is a leading operations management and analytics company that helps our clients build and grow sustainable businesses. By orchestrating our domain expertise, data, analytics and digital technology, we look deeper to design and manage agile, customer-centric operating models to improve global operations, drive profitability, enhance customer satisfaction, increase data-driven insights, and manage risk and compliance. Headquartered in
Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to EXL's operations and business environment, all of which are difficult to predict and many of which are beyond EXL’s control. Forward-looking statements include information concerning EXL’s possible or assumed future results of operations, including descriptions of its business strategy. These statements may include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that we have made in light of management's experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. You should understand that these statements are not guarantees of performance or results. They involve known and unknown risks, uncertainties and assumptions. Although EXL believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect EXL’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors, which include our ability to successfully close and integrate strategic acquisitions, and our ability to respond to and manage emerging public health crises, including the outbreak of the novel coronavirus (COVID-19), are discussed in more detail in EXL’s filings with the
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per share amounts)
| Three months ended |
||||||||
| 2020 | 2019 | |||||||
| Revenues, net | $ | 245,990 | $ | 239,573 | ||||
| Cost of revenues(1) | 162,656 | 157,240 | ||||||
| Gross profit(1) | 83,334 | 82,333 | ||||||
| Operating expenses: | ||||||||
| General and administrative expenses | 28,941 | 32,531 | ||||||
| Selling and marketing expenses | 14,456 | 18,047 | ||||||
| Depreciation and amortization expense | 12,450 | 13,667 | ||||||
| Impairment and restructuring charges | — | 1,227 | ||||||
| Total operating expenses | 55,847 | 65,472 | ||||||
| Income from operations | 27,487 | 16,861 | ||||||
| Foreign exchange gain, net | 1,377 | 1,260 | ||||||
| Interest expense | (3,072 | ) | (3,582 | ) | ||||
| Other income, net | 2,529 | 4,423 | ||||||
| Income before income tax expense and earnings from equity affiliates | 28,321 | 18,962 | ||||||
| Income tax expense | 5,855 | 4,200 | ||||||
| Income before earnings from equity affiliates | 22,466 | 14,762 | ||||||
| Loss from equity-method investment | 55 | 67 | ||||||
| Net income attributable to |
$ | 22,411 | $ | 14,695 | ||||
| Earnings per share attributable to |
||||||||
| Basic | $ | 0.65 | $ | 0.43 | ||||
| Diluted | $ | 0.65 | $ | 0.42 | ||||
| Weighted-average number of shares used in computing earnings per share attributable to |
||||||||
| Basic | 34,401,565 | 34,374,815 | ||||||
| Diluted | 34,720,603 | 34,833,435 | ||||||
(1) Exclusive of depreciation and amortization expense.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share and per share amounts)
| As of | ||||||||||
| (Unaudited) | ||||||||||
| Assets | ||||||||||
| Current assets: | ||||||||||
| Cash and cash equivalents | $ | 224,874 | $ | 119,165 | ||||||
| Short-term investments | 142,539 | 202,238 | ||||||||
| Restricted cash | 6,369 | 5,453 | ||||||||
| Accounts receivable, net | 187,137 | 171,864 | ||||||||
| Prepaid expenses | 11,776 | 13,246 | ||||||||
| Advance income tax, net | 6,024 | 4,698 | ||||||||
| Other current assets | 26,173 | 24,594 | ||||||||
| Total current assets | 604,892 | 541,258 | ||||||||
| Property and equipment, net | 90,513 | 79,142 | ||||||||
| Operating lease right-of-use assets | 99,940 | 86,396 | ||||||||
| Restricted cash | 2,291 | 2,426 | ||||||||
| Deferred tax assets, net | 16,640 | 11,855 | ||||||||
| Intangible assets, net | 69,734 | 73,982 | ||||||||
| 348,076 | 349,529 | |||||||||
| Other assets | 32,045 | 36,016 | ||||||||
| Investment in equity affiliate | 3,128 | 2,484 | ||||||||
| Total assets | $ | 1,267,259 | $ | 1,183,088 | ||||||
| Liabilities and stockholders’ equity | ||||||||||
| Current liabilities: | ||||||||||
| Accounts payable | $ | 8,048 | $ | 6,564 | ||||||
| Current portion of long-term borrowings | 100,666 | 40,867 | ||||||||
| Deferred revenue | 16,038 | 13,436 | ||||||||
| Accrued employee costs | 28,937 | 71,626 | ||||||||
| Accrued expenses and other current liabilities | 84,495 | 71,023 | ||||||||
| Current portion of operating lease liabilities | 18,236 | 24,148 | ||||||||
| Income taxes payable, net | 1,692 | 1,432 | ||||||||
| Current portion of finance lease liabilities | 252 | 253 | ||||||||
| Total current liabilities | 258,364 | 229,349 | ||||||||
| Long-term borrowings, less current portion | 234,820 | 194,131 | ||||||||
| Operating lease liabilities, less current portion | 93,707 | 74,709 | ||||||||
| Income taxes payable | 1,790 | 1,790 | ||||||||
| Deferred tax liabilities, net | 773 | 966 | ||||||||
| Finance lease liabilities, less current portion | 380 | 430 | ||||||||
| Other non-current liabilities | 21,521 | 11,712 | ||||||||
| Total liabilities | 611,355 | 513,087 | ||||||||
| Commitments and contingencies | ||||||||||
| Preferred stock, |
— | — | ||||||||
| Common stock, |
39 | 39 | ||||||||
| Additional paid-in capital | 396,939 | 391,240 | ||||||||
| Retained earnings | 574,314 | 551,903 | ||||||||
| Accumulated other comprehensive loss | (113,104 | ) | (84,892 | ) | ||||||
| Total including shares held in treasury | 858,188 | 858,290 | ||||||||
| Less: 4,497,779 shares as of |
(202,284 | ) | (188,289 | ) | ||||||
| Stockholders’ equity | 655,904 | 670,001 | ||||||||
| Total equity | 655,904 | 670,001 | ||||||||
| Total liabilities and stockholders’ equity | $ | 1,267,259 | $ | 1,183,088 | ||||||
Reconciliation of Adjusted Financial Measures to GAAP Measures
In addition to its reported operating results in accordance with
(i) Adjusted operating income and adjusted operating income margin;
(ii) Adjusted EBITDA and adjusted EBITDA margin;
(iii) Adjusted net income and adjusted diluted earnings per share; and
(iv) Revenue growth on a constant currency basis.
These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles, should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, the financial results calculated in accordance with GAAP and reconciliations from those financial statements should be carefully evaluated. EXL believes that providing these non-GAAP financial measures may help investors better understand EXL’s underlying financial performance. Management also believes that these non-GAAP financial measures, when read in conjunction with EXL’s reported results, can provide useful supplemental information for investors analyzing period-to-period comparisons of the Company’s results and comparisons of the Company’s results with the results of other companies. Additionally, management considers some of these non-GAAP financial measures to determine variable compensation of its employees. The Company believes that it is unreasonably difficult to provide its earnings per share financial guidance in accordance with GAAP for a number of reasons, including, without limitation, the Company’s inability to predict its future stock-based compensation expense under ASC Topic 718, the amortization of intangibles associated with further acquisitions and the currency fluctuations and associated tax impacts. As such, the Company presents guidance with respect to adjusted diluted earnings per share. The Company also incurs significant non-cash charges for depreciation that may not be indicative of the Company’s ability to generate cash flow.
EXL non-GAAP financial measures exclude, where applicable, stock-based compensation expense, amortization of acquisition-related intangible assets, impairment charges of acquired long-lived and intangible assets including goodwill, provision for litigation settlement, non-cash interest expense on convertible senior notes, restructuring charges and other acquisition-related expenses or benefits. Acquisition-related expenses or benefits include, changes in the fair value of earn-out consideration liabilities, external deal costs, integration expenses, direct and incremental travel costs and non-recurring benefits. In addition to excluding the above items, our adjusted net income and adjusted diluted EPS also excludes the effect of incremental income tax expense related to the
A limitation of using non-GAAP financial measures versus financial measures calculated in accordance with GAAP is that non-GAAP financial measures do not reflect all of the amounts associated with our operating results as determined in accordance with GAAP and exclude costs that are recurring, namely stock-based compensation and amortization of acquisition-related intangible assets. EXL compensates for these limitations by providing specific information regarding the GAAP amounts excluded from non-GAAP financial measures to allow investors to evaluate such non-GAAP financial measures.
The information provided on a constant currency basis reflects a comparison of current period results translated at the prior period currency rates. This information is provided because EXL believes that it provides useful comparative incremental information to investors regarding EXL’s true operating performance. EXL’s primary exchange rate exposure is with the Indian Rupee, the
The following table shows the reconciliation of these non-GAAP financial measures for the three months ended
Reconciliation of Adjusted Operating Income and Adjusted EBITDA
(Amounts in thousands)
| Three months ended | ||||||||||||
| 2020 | 2019 | 2019 | ||||||||||
| Net Income (GAAP) | $ | 22,411 | $ | 14,695 | $ | 21,356 | ||||||
| add: Income tax expense | 5,855 | 4,200 | 2,601 | |||||||||
| subtract: Interest expense, foreign exchange gain, net, loss from equity-method investment and other income, net | (779) | (2,034) | (643) | |||||||||
| Income from operations (GAAP) | $ | 27,487 | $ | 16,861 | $ | 23,314 | ||||||
| add: Stock-based compensation expense | 4,778 | 6,956 | 4,532 | |||||||||
| add: Amortization of acquisition-related intangibles | 4,153 | 5,528 | 4,974 | |||||||||
| add: Impairment and restructuring charges (a) | - | 1,227 | 1,375 | |||||||||
| Adjusted operating income (Non-GAAP) | $ | 36,418 | $ | 30,572 | $ | 34,195 | ||||||
| Adjusted operating income margin as a % of Revenues (Non-GAAP) | 14.8% | 12.8% | 13.3% | |||||||||
| add: Depreciation | 8,297 | 8,139 | 7,541 | |||||||||
| Adjusted EBITDA (Non-GAAP) | $ | 44,715 | $ | 38,711 | $ | 41,736 | ||||||
| Adjusted EBITDA margin as a % of revenue (Non-GAAP) | 18.2% | 16.2% | 16.2% | |||||||||
| (a) To exclude impairment and restructuring charges related to wind down of the Health Integrated business. |
Reconciliation of Adjusted Net Income and Adjusted Diluted Earnings Per Share
(Amounts in thousands, except per share data)
| Three months ended | |||||||||||||
| 2020 | 2019 | 2019 | |||||||||||
| Net income (GAAP) | $ | 22,411 | $ | 14,695 | $ | 21,356 | |||||||
| add: Stock-based compensation expense | 4,778 | 6,956 | 4,532 | ||||||||||
| add: Amortization of acquisition-related intangibles | 4,153 | 5,528 | 4,974 | ||||||||||
| add: Impairment and restructuring charges (a) | - | 1,227 | 1,375 | ||||||||||
| add: Non-cash interest expense related to convertible senior notes | 636 | 600 | 636 | ||||||||||
| subtract: Non-recurring tax benefits | - | - | (1,663) | ||||||||||
| subtract: Tax impact on stock-based compensation expense (b) | (2,733) | (2,481) | (2,144) | ||||||||||
| subtract: Tax impact on amortization of acquisition-related intangibles | (897) | (1,193) | (1,042) | ||||||||||
| subtract: Tax impact on impairment and restructuring charges | - | (301) | (352) | ||||||||||
| subtract: Tax impact on non-cash interest expense related to convertible senior notes | (156) | (147) | (159) | ||||||||||
| Adjusted net income (Non-GAAP) | $ | 28,192 | $ | 24,884 | $ | 27,513 | |||||||
| Adjusted diluted earnings per share (Non-GAAP) | $ | 0.81 | $ | 0.71 | $ | 0.79 | |||||||
| (a) | To exclude impairment and restructuring charges related to wind down of the Health Integrated business. |
| (b) | Tax impact includes |
Contact:
Vice President, Investor Relations
(212) 624-5913
ir@exlservice.com
Source: ExlService Holdings, Inc.